-
New Capsules Being Readied for Trial of Digestive Enzyme for CF with EPI
Delpharm will manufacture MS1819 using enteric (slower dissolving) capsules for a Phase 2b trial in CF patients with exocrine pancreatic insufficiency. Read more here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.